Title |
The effect of omeprazole on the development of experimental autoimmune encephalomyelitis in C57BL/6J and SJL/J mice
|
---|---|
Published in |
BMC Research Notes, September 2014
|
DOI | 10.1186/1756-0500-7-605 |
Pubmed ID | |
Authors |
Scott A Sands, Sheila Tsau, Thomas M Yankee, Brooks L Parker, Aaron C Ericsson, Steven M LeVine |
Abstract |
Gastric disturbances such as dyspepsia are routinely encountered by multiple sclerosis (MS) patients, and these conditions are often treated with gastric acid suppressors such as proton pump inhibitors, histamine H2 receptor antagonists, or antacids. The proton pump inhibitor omeprazole can alter the gut flora and immune responses, both of which can influence the course of experimental autoimmune encephalomyelitis (EAE), an animal model of MS. The objective of the current study was to examine the effect of omeprazole treatment on the development of EAE. Bacterial microbiome analysis of mouse fecal pellets was determined in C57BL/6J EAE mice chronically treated with omeprazole, and spleen immune cell content, clinical scores, weight, rotarod latency, and histopathology were used as outcome measures in C57BL/6J and SJL/J mice with EAE. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Members of the public | 1 | 50% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 1% |
India | 1 | 1% |
Germany | 1 | 1% |
Unknown | 79 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 16 | 20% |
Student > Master | 15 | 18% |
Student > Ph. D. Student | 13 | 16% |
Student > Bachelor | 8 | 10% |
Other | 6 | 7% |
Other | 12 | 15% |
Unknown | 12 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 23 | 28% |
Medicine and Dentistry | 11 | 13% |
Biochemistry, Genetics and Molecular Biology | 9 | 11% |
Immunology and Microbiology | 6 | 7% |
Neuroscience | 4 | 5% |
Other | 17 | 21% |
Unknown | 12 | 15% |